Specific constitutional treatment of cancer by Pepper, Maurice L.
University of Nebraska Medical Center 
DigitalCommons@UNMC 
MD Theses Special Collections 
5-1-1936 
Specific constitutional treatment of cancer 
Maurice L. Pepper 
University of Nebraska Medical Center 
This manuscript is historical in nature and may not reflect current medical research and 
practice. Search PubMed for current research. 
Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses 
 Part of the Medical Education Commons 
Recommended Citation 
Pepper, Maurice L., "Specific constitutional treatment of cancer" (1936). MD Theses. 461. 
https://digitalcommons.unmc.edu/mdtheses/461 
This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It 
has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For 
more information, please contact digitalcommons@unmc.edu. 
THE SPECIFIC CONSTITUTIONAL TREATMENT OF CANCER 
A REVIEW 
by 




The physician and medical student may have heard 
mention of constitutional methods of treatment of cancer. 
Such methods are seldom referred to in textbooks or class-
rooms, but are occasionally presented at medical meetings, 
especially those primarily interested in the study of 
malignant disease. The infrequent and sometimes casual 
references made to the subject will fail to impress one 
of t ts scope, ancl of the immense amount of work whi ch 
has been done in an attempt to find a therapia magna 
sterilisans for cancer. Furthermore, one who presents 
posi ti ve findtngs is apt to omi t reference to n"nmerous 
studies which have yielded negative results and thus 
leave his audience with a distorted outlook on the subject. 
It is, therefore, to orient the student tm this field of 
cancer research, to survey a large group of methods and 
substances proposed for the specific constitutional 
treatment of cancer, and to reach some conclusions as 
to their value, potential and. attained, that this paper 
is written. 
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THE SPECIFIC CONSTITUTIONAIJ TRl'~ATMENT OF CANCER 
I 
INTRODUCTION 
SCOPE. --Thj.s paper is a review of the treatmt;nt of cancer 
by substances and methods which are introduced into the 
body distal to the tumor and which exert a specific 
deleterious action, directly or indirectly, upon the 
cancer cell, resulting in regression of the tumor and 
cure of the affected patient. Included are chemicals, 
gland and ttsslle extracts, bacteria and their growth 
products, body flutds, toxins, ana a number of physical 
methods. While certain immunologic methods are of this 
general nature, they are not inclucled here because of 
some rather fundamental differences in the problems 
involved and because the subject is so voluminous as to 
merit a special study of its own. It has recently been 
thoroughly reviewed by 'Noglom (1929) and Caspari (1929). 
Obviously excluded from consideration by the stated scope 
of this paper are methods of prevention of cancer, treat-
ment by dietary restrictions, and treatment by removal 
of organs of internal secretion. Numerous publications 
have, from time to time, accepted a method of constitutional 
treatment which was a current favorite and described it 
without citing observations regarding its value, but as 
this is written with some view to estimating the value 
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of proposed methods, such publications are not considered 
here. Quacks have often employed constitutional methods 
to treat cancer patients but are deserving of no consider-
ation. 
GENERAl, CONSIDERATIONS OF CANCER BEARING on TREATMENT.--
A tumor is defined by Ewing (1922) as an autonomous new 
growth of tissue. Such growths subserve no useful function 
and are largely uncontrolled by the organism. Tumors 
are divided into benign tumors and. malignant tumors or 
cancers. The latter group consists of those tumors which 
exhibit certain features which are essentially deleterious 
to the host, most important of which are lnflltrative 
growth, local destruction of tissue, recurrence after 
removal, formation of metastases, local interference with 
functlon, and general toxlc action of absorbed tumor 
products. 
There are numerous theorj.es as to the cause 
or causes of cancer, but no general single cause has as 
yet been proven. The following theories are particularly 
well known: the embryonal rest theory of Cohnheim, the 
tissue tension theory of Ribbert, the theory of tissue 
growth of Adami, irritation, heredity, metabolic derrange-
ment, and specific parasite. Most of the theories are 
not entirely satisfactory because the postulated cause 
cannot be shown to operate in a majority of the cases of 
cancer and because the cause can be present without 
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resulting in cancer. Often a supposed cause has later 
been shown to be only a phenomenon which is part of the 
capcer process itself or which is secondary to the neo-
plasm. It has become necessary, therefore, to suppose 
a multiplicity of factors to be involved, varying in 
different cases,--some are exciting and some are predis-
posing, some are general and some are local, some acquired, 
some hereditary. If cancer is a parasitic disease (there 
is much evidence to show that it is not), it is important 
from the point of view of treatment to determine whether 
the continued presence of the parasite is necessayy for 
the continued growth of the malignant cells once the 
process has been initiated (Boyd, 1925). 
Regardless of the cause of cancer, it is gener-
ally accepted that the process is itself specific, the 
growing cancer celIs constituting, as it were, an invading 
"orga,nism!l. The cells are specific in their property of 
unlimited and unrestricted growth as a result of perver-
sion of norMal functional and nutritive relations. The 
energy for excessive growth is liberated by abnormally 
excessive carbohydrate cleavage (Warburg, 1931). Other 
properties of cancer cells are atypical structure, increased 
permiability, abnormal lipid relations, electrical reactions, 
response to calcium salts and intracellular water content, 
and excessive co-ferment primary in the cleavage of 
dextrose (Eggers, 1932). Factors contributing to the 
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increased reproductive capacity are inherent growth 
energy, heredity, hormonal imbalance, and, probably 
of greatest importance, factors as yet unknown. 
The well known property of cancer to invade 
and metastasize, which often renders local treatment 
incomplete, makes a specific constitutional method of 
treatment desirable. With all treatment at the present 
time consisting of local excision or destruction, the 
best medical skill attains only about fifteen percent 
of definitive cures for all types of cancer (Haagensen, 
1933). Failures result from incomplete removal. 
While the percentage of cures will undoubtedly be 
improved by earlier diagnosis and improved technique, it 
can never approach the results to be attained with a 
successfulconsti tlltional form of treatment. The 
importance of this field, therefore, lies jn the treatment 
of cases advanced beyond the hope of successful surgery 
or irradiation and in prophylaxis against recurrence 
following excision or destruction. 
At present, there is no method proven success-
ful in any high percentage of cases. The methods attempted, 
however, will be reviewed and their results evaluated. 
SPECIFIC CONSTITUTIONAL TREATMENT.--A large number of the 
methods reviewed here may be classed as chemotherapeutic. 
Some of the specific constitutional methods, however, 
such as the use of hormones and bacterial growth products, 
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could only que~tionably be called chemotherapeutic, 
while others, such as fever therapy, in no sense fall 
into this realm. The attempt is to review all methods 
not specifically excluded. 
Chemoth rapy, as stated, does playa large 
part in the speci ic constitutional treatment of cancer. 
Barger (1930) def nes chemotherapy as the use of drugs 
on which chemical work has been done, usually synthetic 
substances, alkal ids or their derivatives, in the treat-
ment of parasitic disease, acting by its toxic effect 
on the specific c agent. Kolmer (1926), however, 
states that in th modern sense chemotherapy includes the 
treatment of para itic disease by more or less specific 
disinfection of tissues without marked or serious 
toxic effect on t e host. The chemotherapeutic agent 
need not necessar ly be monoparasitotropic and it may 
act indirectly by production of leukocytosis, stimulation 
of phagocytosis 0 other immune defense as well as directly 
upon the parasite He discusses such fundamental concep-
tions as parasito ropism and organotropism, chemothera-
peutic index, lea sand chemoreceptors. 
Kolmer 1926) considers the use of chemotherapy 
in cancer as depe dent upon the etiology of cancer: (1) 
if due to a chang in cells resulting from prolonged 
irritation, a substance which will destroy the cells 
nroduced must be found; (2) if due to specific virus 
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alone, discover a specific destructive chemical agent 
for it; (3) if due to chemical irritation, chemotherapy 
could not remove it; (4) if clue to irritation produced 
by a specific or non-specific organism, the chemothera-
peutic substance would have to destroy the organism 
causing the irritation and the cells already changed. 
Findlay (1930) regards the cancer cells as specific; 
any chemotherapeutic method must destroy all the cancer 
cells by its direct lethal action upon the malignant 
cells, by destruction of the blood vessels to the tumor, 
or by stimulation of defensive and fixed tissue cells. 
The first of these possibilities, direct destruction of 
the tUMor cells, is ideal, but very difficult because of 
the great similarity of cancer cells to normal cells. 
The metabolic difference detected by Warburg is suggested 
as an important basis for rational therapy. 
GENERAL CONSIDERATION OF THE METHODS.--The many substances 
and methods which have been proposed for the specific 
constitutional treatment of cancer may be classified as 
follows: (1) metals and metallic compounds; (2) other 
inorganic compounds; (3) other organic compounds; (4) 
a miscellaneous group of substances including hormones 
and tissue extracts, bacteria and their growth products, 
toxins, and body fluids; and (5) physical methods,--fever 
therapy, gas inhalation, and modification of fluid balance. 
The usual dose of the substance employed is 
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sufficient1y large thq,t its toxicity is of great importance, 
although a few are used in relatively non-toxlc doses. 
Since highly toxic doses of substances are dangerous, 
their use is impractical and they are without value. 
Every known Method of administration has been used, but 
since the effect of intratumoral injection may not be 
constitutional, repnrts of such treatment are not included. 
~lbjects for the investigation of proposed 
remedies have been animals bearing various types of 
experimental cancer and human inoperable cancer. Objec-
tion has frequently been raised to reports based upon 
the use of one type only of animal tumor and to the 
use of transplantable tumors. Provided the experiments 
are properly controlled and the animal work is used only 
to get leads as to posstble value in treatment of human 
cases, no valid objection can be raised. 
The substances and methods used have produced 
a great variety of local and general effects. Some 
observers have gone to great lengths to describe in 
minute detail these changes. For our purposes, such 
descriptions serve only to cloud the true results, for 
we are interested here only in destruction of the cancer 
and cure of the victim. Because of the results of their 
experiments, most observers reach some conclusions as to 
the value of their form of treatment. These are given 
where they have been made and discussed later in the 
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light of certain criteria. 
Weil, who was one of the early workers in the 
field of chemotherapy in cancer, sought some basis for 
evaluation of the results of his experiments and those 
of others. He concluded (1913) that "the demonstrable 
reduction in size of a tumor, of a kind not to be attri-
b11ted to the natural processes of evolution of that tumor 
or of its associated lesions, is the one essential feature 
of effective therapeutic intervention." By way of ex-
planation and expansion, it may be stated that this 
refers to established, proven Malignant tumors, that 
they must be reduced in size and metastases must not 
clevelop, anct that the natural process of evolution of 
the tumor and its associated lesions must be noted in 
untreated controls and conclusions based upon differences 
in the two sertes. Furthermore, that the remedy may 
be constdered specific, it must be effective in a 
significant percentage of the cases treated. In human 
cases, the percentage of five year cures computed according 
to the rules laid down by the cancer commission of the 
health organizatton of the League of Nations (1929) 
constitutes a second necessary criterion for the evalua-
tion of the results of treatment. The above are reasonable 
and necessary yardsticks, yet the majority of investigators 
in thls field are unaware of the necessity of basing their 
conclusions on these or any other guides. 
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THE SPECIFIC CONSTITUTIONAL TREATMENT OF CANCER 
II 
HISTORY 
CANCER.--The history of our knowledge of cancer is divi-
ded by Ewing (1922) into four periods. The first of 
these began in the earliest times and lasted until 
about 1661. The earliest medical documents, the Papyrus 
Ebers, about 1500 B. C., refers to tumors in general, 
but there is no clear reference to cancer. Lipoma is 
clearly described,--it is treated "with the knmfe". 
Hippocrates (460-375 B. C.) knew cancer 'well and 
described many forms. He advised against treating 
deep-seated lesions; only cautery and various caustic 
pastes were recommended. Galen (130-201 A. D.) made 
no significant contribution to the knowledge of ~ither 
the cause or treatment of cancer; his work is important 
only because his authority was so great that he crystal-
lized medical thought and obstructed progress in the 
investigation of cancer until after the Renaissance. 
The humoral pathology by which deficiency or excess of 
bile, blood or mucous formed the basis of all disease 
disseminated conceptions of the ortgin of cancer and 
prevented progress for near}y two thousand years. In 
his classification, Galen included many inflammatory 
lesions, localized edemas, gangrene, and other affec-
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tions which he could not understand with true tumors. He 
attributed cancer to an excess of black bile. Local 
treatment of cancer improved somewhat, but the ideas as 
to the nature of the disease remained about the same 
until the lymph theory of Ma1phigi began the second 
period in our knowledge of cancer in 1661. 
Harvey discovered the circulation of the 
blood in 1628; Olens discovered the lymph vessels 
in 1652; Malphigi discovered the red blood corpuscles 
in 1661. Lymph coagulated and foamed on boiling, hence 
cancer was composed of lymph varying in density, alka-
lescence or acidity. Galen's doctrine was demolished. 
The lymph theory dominated thought until 1852. Morgagni's 
work in 1761 constituted the beginning of pathology and 
the beginning of the description and fl.lassification 
of cancer. Schwann showed that all living matter was 
composed of cells in 1838, and Johannes Muller founded 
microscopic pathology at about this time, but held to 
the lymph theory. 
It remained for Virchow in 1858 to begin the 
histologic period of our knowledge of cancer with his 
dictum "omnis cellula e cellulaf!. Virchow believed that 
all malignant tumors arose heterologously from connective 
tissue. Thiersch corrected this in 1865 by changing 
Virchow's dictum to !Tomnis cellula e cellula ejusdem 
generis". 
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The present period in the study of cancer is 
the experimental period, which began with the Twentieth 
Century. It began with the successful transplantation 
of a spontaneous carcinoma of the vulva of a rat to the 
testis of several male rats by Hanau in 1889. Jensen 
carried a mouse carcinoma through nineteen generations 
in a classical study in 1903. 
CHEMOTHERAPY. -- "From the earliest times hea:1ers of the 
sick have sought specific remedies in the" form of drugs 
or methods that would always and unfailingly cure the 
effect of a certain disease" (Kolmer, 1926). Many 
substances have been used and mostly discarded. At the 
beginning of the modern era, there were only three of 
proven value,--mercury for syphilis, since 1500, and 
cinchona bark for malaria and ipecacuanha for dysentary, 
since the Seventeenth Century. 
Modern chemotherapy began with Ehrlich who, 
stimulated. by Heubel on lead poisoning. idealized "that 
the ways and means by which d~lgS are distributed over 
the body must be of great importance in the rational 
development of therapeutics." ·His work with the arseni-
ca1s in the treatment of syphilis began the modern era 
of rational chemotherapy. 
CHEMOTHERAPY IN CANCER.--Constitutional methods have been 
used in the treatment of cancer since earliest times. 
Cato administered charcoal an~ variety of crude internal 
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remedies were mentioned by Pliny. Avicenna (980-1037) 
administered arsenic internally. Fabricius (1537-1619) 
experimented with various internal remedies. With the 
decline of Galen's authority in the Seventeenth Century, 
treatment was demoralized; arsenic and other internal 
remedies were abused. Helmont and Ettmuller thought 
cancer due to an excess of acid and treated it with 
alkali. Hoffman applied his anodyne to restore tissue 
tone. Goulard used a lead preparation, lead subacetate, 
locally in 1760. Torres first used colloidal metals in 
1904 (see Waters, Colston and Gay, 1929). 
The rational investigation of the application 
of specific constitutional Methods of treatment to cancer 
depended primarily upon the existence of a rational 
chemotherapy as founded by Ehrlich. Experimental methods 
of cancer research, while not absolutely essential, were 
very desirable, and were most important for the inves-
tigation of the value of a large number of substances in 
the specific constitutional treatment of cancer. 
The modern history of the specific constitutional 
treatment of cancer began with the use of killed cultures 
of streptococcus ery~ipelas in the treatment of animals 
bearing spontaneous neoplasms by Spronck in 1892 and 
with the use of the mixed toxins of Streptococcus erysi-
pelas and Bacillus prodigiosus in the treatment of human 
cases of inoperable malignancy by Coley in 1893. 
-- 15 --
The first wo~k with chemotherapy proper was 
that of Wassermann, Keysser, and. Wassermann, reported to 
the Berlin Medical Society in 1911. They treated mice 
that had been innoculated with transplantable tumors 
with an eosin-selenium compound, thinking that the 
eostn would carry the toxic selenium into the cancer 
ce lIs. They be Ii e,red that they haa. cured a few animals, 
but their preparation was soon shown to be without value. 
Their work, however, had attracted wide attention and 
others were led to 8i~ilar attempts. Leob, et aI, in 
this country, reported on the use of copper compounds 
in 1912. 
For the most part, the subsequent history of 
the speoific constitutional treatment of cancer is the 
history of the use of the individual s11bstances and. 
methods which have been proposed. 
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THE SPECIFIC CONSTITUTIONAL TREATMENT OF CANCER 
III 
METALS AND METALLIC COMPOUNDS 
Metals have played a most important role in 
the treatment of cancer. Where they have been used, the 
action of the compound has been, for the most part, 
ascribed to the effect of the metal. Whether or not 
the action of the substance is in every case due to the 
metallic constituent, such an assumption serves as a 
convenient basis for classification. Caspari (1928) 
theorizes as to the action of all heavy metals. He 
believes they increase the autolytic processes of cells, 
all thus having a general harmful effect on tumors. 
The colloidal form has been believed especially useful 
for various reasons, probably the most valid of which 
is the idea that metals are less toxic in such form 
than in compounds in which the metal is ionized. 
Before constdering the tndtvidual metals, it 
seems desirable to discuss four papers which have each 
reported upon the use of a large number of metals and a 
few non-metals in the therapy of tumors in animals. 
Ishiwara (1927) investigated the effect of compounds of 
fifty-eight different metals upon mice bearing the Bash-
ford carcinoma No.63. He divided these substances into 
four groups on the basis of their effect. All the metals 
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to be mentioned later with the exception of sodium, 
potassium and chromium were included in the tests. To 
test the validity of the positive results reported by 
Ishiwara, Simpson and Marsh (1931) and Marsh (1934) 
investigated the effect of one hundred nine compounds 
upon albino mice bearing spontaneous mammary adenocar-
cinoma. They included all the metals of Ishiwara's 
series except praseodymium, niobium, ytterbium, and 
terbium (the latter three were classed as effective by 
Ishiwara). All the substances mentioned later in this 
paper except praseodymium were included in one of these 
papers. Not one of the one hundred nine compounds em-
ployed showed any evidence of therapy, macroscopic or 
microscopic, upon the tumor or its growth. All three 
papers include substances which are not cons5. dered later 
because the only reference to· the use of such substances 
in the treatment of animal or human tumors is in these 
papers. The results of Maxwell and Bischoff (1931) were 
negative for all substances employed on the rat sarcoma 
No. 10 except praseodymium nitrate. With the Hyde rat 
carcinoma, all their results were negative. 
LEAD.--Goulard introduced lead for the local treatment 
of cancer in 1760, but it was not until the work of W. 
Blair Bell in 1922 that attention was called to its 
possible constitutional use. Bell had observed the 
frequency with which spontaneous abortion occurred in 
-- 18 --
women employed in the lead industry. He reasoned that 
this was due to a specific harmful effect exerted by the 
lead upon the embryonal cells such as occur in the chori-
onic villi. Cancer cells resemble those of the chorionic 
villi in their primitive structure and invasive tendencies, 
and should, there~ore, likewise be harmfully affected by 
lead. Furthermore, on the basis of the work of Bullock 
and Cramer (1913-14), who showed that certain transplan-
table tumors of the mouse and rat had a tendency to a 
higher content of phosphatids and cerebrosides than normal 
tissue and that the content was higher in rapidly growing 
tumors than the more slowly growing ones, Bell argued 
that the action of the lead consisted of a combination 
with the lecithin of the tumor cells. Of thelr numerous 
communications, several have dealt solely with these 
theoretical considerations and their experimental proof 
(Bell et all, 1925). Other investigators have contended, 
however, that lead acts on the vessels of the tumor. 
Animal Tumors.--Wood (1926) used colloidal 
lead on a group of nine hundred white rats bearing a 
transplantable carcinoma and two transplantable sarcomas, 
all highly virulent. The tumors were greatly affected,--
there was extensive necrosis in most, but all but a few 
recurred. A very few (number unstated) were completely 
absorbed. Wood believed that the lead caused thrombosis 
of the newly-fo:rmed., fragile vessels of the tumor. 
Girard (1927) found lead to be the best of a group of 
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metals applied by electrical endosmosis to a spindle-
celled rat sarcoma, causing absorption which was some-
times complete. Veachi (1930) used twenty-five albino 
rats implanted with osteoid sarcoma; there were twenty-
four takes. Using nine as controls and dividing the 
remainder into three groups of five, he found that the 
treated animals had smaller tumors at every observation 
period over a period of forty days except the first (fif-
teen days). Wood (1927), in a later work, found that 
colloidal metallic lead combined with irradiation was 
more effective on the rat sarcoma no. 10 and on the 
Flexner-Jobling rat carcinoma +.han either lead or irra-
diation. Dextrose failed to increase the effectiveness 
of either the lead or irradiation. The Jensen rat 
sarcoma was uninfluenced by lead salts injected intra-
muscularly in oil (LeGuyon, 1931). Eggers (1934) 
treated animals inplanted with the FRC carcinoma and 
the R39 rat sarcoma with lead salts of acids derived 
from a group of hexose sugars in an attempt to utilize 
the metabolic peculiarity of cancer cells discovered by 
Warburg. While the glycuronate, galactonate and gluco-
heptonate were successful in a few cases, Eggers considered 
his results with these compounds unsatisfactory. 
Mottram (1928) investigated the effect of 
combined lead and irradiation on mouse carcinoma T63. 
(Tumors disappeared following combined therapy in snch 
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doses of each as would be ineffective alone. He concluded 
that the action was a summation of the effects of each; 
also tha-t the sllbstances acted upon the vessels of the 
tumor, partly by secondary radiation, and that the 
results were sufficiently encouraging to warrant tr~al 
in human cases. Krause, and later Collier, have under-
taken the investigation of a number of organic lead 
compounds in an effort to modify the toxicity of the 
product and maintain its therapeutic potency. Krause 
(1929) first reported upon the investigation of a group 
of such compounds on mice with experimental carcinoma. 
n-propyl lead flouride (n-C3H7)3PbFl was especially 
effective in the prophylaxis and treatment. Collier 
(1929) tested Krause's compounds on mice two hours after 
innoculation with the Ehrlich carcinoma. While all 
of three hundred controls died in four to stx weeks, 
the treated animals frequently showed no growth Whatever, 
or growth to a small size with later regression. Best 
results were wtth n-propyl lead flouride and tetra-
phenyl lead. In 1929, Collier also investigated the 
effect of fifteen inorganic and org~nic lead salts on 
transplantable mouse tumors, most of which inhibited 
growth in twenty to thirty percent of the cases. The 
best results were with the tannate, oxalate, malate, 
and citrate, and especially with the formate, which 
retarded nearly sixty-five percent and caused the dis-
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appearance of thirty-five percent. Collier and Krause 
(1931) treated mice with solutions of heavy metal com-
pounds two days after innoculation with the Ehrlich 
carcinoma. Most active were K(PbC13 ) and K(Pb 2C15 ). 
Krebs and Clemmesen (1934) gave R237b (see below) to 
one hundred mice with Krebs 2 carcinoma, a tumor that 
has not yet receeded spontaneously. There was no differ-
ence in the controls and the treated animals. 
Collier (1932) found the potassium salt of 
plumbo-dithio-pyridincarboxylic acid, called R232, to 
retard the growth of the Brown-Pearce rabbit carcinoma, 
and to prevent the development of metastases. While 
Krebs and Clemmesen had some succeas with this compound 
and its sodium salt (R237h) on the Brown-Pearce rabbit 
carcinoma and in leukoses of fowls, they found the latter 
of no value in a monse tumor. While Bell published his 
first paper on the treatment of cases of human malignant 
disease in 1922, it was not untll 1935 that his organi-
zation investigated the value of lead compounds in the 
treatment of animal tumors. At that time, a group of 
twenty-seven organic lead compounds were tested by the 
Liverpool Medical Research Organization under M. Datnow. 
The Brown-Pearce rabbit carcinoma was used, and of the 
twenty-seven compounds, seven were entirely unsuitable 
because of their toxiCity and five had been only partially 
tested. Some of the others will be used in human cases. 
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Results following the use of manganese combined 
with lead phosphate on rats with sarcoma 39 lead Kraemer 
(1931) to advocate the use of this combination in cases 
of human cancer. Marsh and Simpson (1927) treated female 
albino house mice bearing spontaneous mammary carcinomas 
with lead tetra-ethyl. It had no effect except in lethal 
doses. 
Dilling (1928) and a number of other observers 
have reported coneentration of lead in tumors. Reinhard 
and Buchwald (1929) treated mice bearing spontaneous 
mammary carcinoma:s of various duration with varied 
doses of lead colloid. They examined they tumors spec-
troscopically and by two chemical methods and could find 
no lead whatever in the tumors. 
Human.--Bell employed various preparations 
of colloidal metallic lead. A colloidal preparation 
was used because it was thought to be less toxic than 
other compounds. His first paper (1922) set forth the 
theoretical consid.erations upon which the work was based 
and gave the results of his early clinical experiments. 
Inoperable cases were selected and, while none were 
refused, it was though t that the patient should be able 
to live six months without treatment to be a good risk. 
Lead was found in the tumors in considerably greater 
concentration tha:n in the other tissues and was thought 
to increase the sensitivity to irradtation. As much of 
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the growth as possible should be excised to prevent 
toxic absorption and to reduce the amount of treatment 
necessary. Fifty cases were treated over a two year 
period and four of the thirty-five receiving a complete 
course of treatment were considered cured. Two of these 
had been treated '"i th lead alone and two had combined 
irradiation and lead therapy. Reports on the progress 
of his work were made by Bell and his co-workers in 
1924, 1925 and 19:29. The 1929 report, which is the 
last one made (Be 11 died early in 1936) t include s a 
total of 566 case:s, treated over an eight year period 
ending in November, 1928. Of these, 450 died; 22 dis-
continued treatmeYlt; 12 were completely arrested; 51 were 
believed cured anll treatment stopped; and 31 were recent 
cases. Thus, of the 315 having adequate treatment, 63, 
or twenty percent, had satisfactory resu~ts. Slightly 
over ten percent of the whole series had satisfactory 
results. 
Follwwi:ng the work of Bell, Stone and Craver 
(1927) treated six cases successfully wtth colloidal 
lead out of a total of twenty-one. Four were primary 
bone tumors. A case of chorioepithelioma was unaffected. 
Wood (1928) treated forty patients who had inoperable or 
recurrent malignancy. Four were living and well after 
a year with no sign of neoplasm, and the tumors had com-
pletely disappeared in two others that died of inter-
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current disease. Colloidal metallic lead and irradiation 
were used. Rume (1928) treated thirteen cases with 
Bell's preparation S7 alone with no improvements, but 
noted improvement in two of seven cases in which irradi-
ation was combined with the lead. Soiland, Costalow, and 
'Meland (1928) treated a series of eighteen cases and 
arrested one case of carcinoma of the cervix which had 
previously been treated with radium for an unspecified 
length of time. Knox (1929) treated forty patients, of 
which four were well and wholly free of all signs of 
cancer at the end of a short period of observation. 
Brunner (1929) reported definite improvement of an un-
stated nature in seven of fifteen patients. Brunton (1930) 
co~pleted the treatment of thirty-four patients with S7. 
There were two clinical cures of a duration of three 
years. 
O'Crowley (1926) treated two cases of epitheli-
oma of the penis with colloidal metallic lead. They were 
unaffected. Talbot (1928) failed to cure two cases of 
cancer but thinks their lives prolonged. Hey (1928) 
noted no effect on twenty cases. Eight cases of Kaemmerer 
(1928) received adequate dosage without being in any way 
improved. Wyard (1928) reported on fifty-six cases 
treated at the Cancer Hospital, London, with one good 
result in an unproven lymph node recurrence of a cancer 
of the breast. From his own observations, he concluded 
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that lead is of no use in the treatment of cancer, and 
from other reports available at the time, he concluded 
that there was no reason why lead should be of use and 
no evidence that it is. All of the seventeen cases treated 
by Schreiner and Wende (1929) died or metastases occurred. 
The results of Mattina (1930) on twenty cases were simi-
lar. Da~imier and Schwartz (1934) treated seven cases 
with a colljodal metallic lead preparation and seventeen 
cases with lead phenylamy1acetate. The end results in 
these cases were unchanged, and the authors concluded 
that the treatment had been without value. 
Colloidal lead phosphate has had considerable 
vogue in treating malignant disease. Ullmann (1928) 
reported two cases greatly improved out of a series of 
cases treated. In a later report (1929) on fifty-seven 
cases, five had responded favorably and five were too 
recent for evaluation. Osterberg, Horton, Bargen, and 
Rankin (1932) treated ninety-five cases with colloidal 
lead phosphate at the Mayo Clinic. Of the forty-eight 
cases receiving what the authors considered adequate 
treat~ent, twenty-six died and twenty-two were living 
at the time of the writing, six months to two and one 
half years after beginning treatment. Nine were clinically 
free of all signs of neoplasm. In a later series of 
eighty-one cases treated, for the most part, with combined 
lead and irradiation (1935), sixty are known dead, 
-- 26 
seven are either not traced or are known to have recur-
rences, and thirteen are living and cltnically well after 
at least two years. Of the latter group, seven received 
lead alone and six received lead and irradiation. Thus, 
about sixteen percent were successfully treated. Aub 
and Smithwick (1933). however, treated twelve patients 
who were in relatively good condition despite the presence 
of an inoperable neoplasm, using combined lead and itra-
diation, and not only failed to attain any successful 
results but felt that the patients were made worse and 
their duration of life shortened by the treatment. 
Sojland, Costolow and Meland (1929) li~ewise failed to 
cure any of thirty-one cases with the combined treatment. 
Other lead preparations have been used, and 
some have tried several lead preparations, or lead and 
some other substance, in a series of cases. Thomson 
(1928) used colloidal lead (choriotrope), lead glycine 
and lead phosphate in a group of fifty-five cases. Six 
were too recent for evaluation, while only five were 
improved. Coke and Cook (1926) experimented with several 
lead. compounds and apparently cured one case wi th lead 
and. XTray. Dentici, Moratti and Pattarin (1929) treated 
twenty-five cases with a lead. preparation. Two which had 
not been biopsied completely regressed, three partially 
regressed, sixteen died, and seven had not comp!eted the 
treatment. Waters, Colston and Gay (1929) had poor 
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results with two series of cases in which a lead compound 
had been combined with irradiation. Costa (1930) treated 
seven oases with lead "Dezani ff , a proprietary preparation, 
with no cures. Sohlurch (1933) treated thirty-two Oases 
of inoperable oarcinoma with lead iodide in caleium 
gluconate solution and noted no objeotive improvement 
attributable to the lead in any oase. Simpson (1928) 
treated nineteen oases with a lead preparation. Eighteen 
died and the other one was unimproved. Colloidal lead 
oxide was used by Loewy and Loiseleur (1928) in the treat-
ment of twenty-one oases. Looalization of the lead in 
the t 11mor was noted and arrest of clevelopment of the 
tumor was thought to oocur in four cases. A later report, 
however, faileC! to confirm the early favorable results 
(1928). Fry (1928) found no histologioal changes in 
growths treated with lead not observed in untreated tumors. 
Todd and his assooiates (1928) worked with 
compounds of lead and selenium, based on previous olaims 
of value in eaoh. Their first report on forty-four 
oases treated with colloidal lead selenide (D4S) recorded 
no cures, but retardation of growth occurred in eight 
oases and twenty-five died. They warned against the use 
of this substanoe oombined with irradiation (1929). In 
1930. Todd reported on the progress of his work, and in 
1934 the last available report was made. He believes that 
the treatment stimulates the natural body defense against 
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invasion by the c~ncer cells. The original preparation, 
D4S had proven unsuccessful and the use of it (liscontinued 
in favor of selenium preparations containing no lead. 
COPPER.--Copper compounds were among the first SUbstances 
to be widely tried experimentally for the chemotherapy 
of cancer. Loeb began j.ts use in this country in 1912, 
while a group of observers were favorably impressed in 
Europe. 
Animal Tumors.--Loeb (1913) used a group of 
preparations of colloidal metallic copper in mixture with 
casein and claimed to have cured a few mice bearing a 
transplantable adenocarcinoma. Next, a group of substan-
ces"including platinum, sulfur, lanthanum, and ethyl-
hydrocuprein, were tried in compination with .colloidal 
copper (Loeb and Fleisher, 1913). All were ineffective. 
Of a group of proteins, casein and nucleoprotein alone 
were effective, but no cures resulted. Finally, colloidal 
copper and colloidal copper combined with casein or 
hirudin were found to inhibit the growth of nine to 
thirteen day old mouse carcinomas, being more effective 
in smaller, more rapidly growing tumors than in larger, 
more slowly growing ones, these results being reported 
by Fleisher and Leob in 1914. Heuberg, Caspari and Lohe 
(19l2) were unable to find tumor cells in mice cured by 
a copper preparation of spontaneous and transplantable 
tumors. Their later work failed to confirm these good 
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results. These authors proposed the theory that since, 
according to Petri, tumor cells had increased Quantities 
of autolytic ferments, and according to Tzar, colloidal 
metals increase the activity of autolytic ferments, 
therefore, the colloidal metals a~fected cancer cells by 
enhancing autOlysis. This theory has never been confirmed. 
Szecsi (1912) was unable to attain satisfactory results 
with colloidal copper. Keysser (1914) found. that while 
the colloidal copper glycine of Neuberg cured some cases 
of subcutaneous innoculated tumors of mice, it was of no 
value whatever in infiltrating tumors and metastases of 
organs. Cells of a transplantable tumor suspended in it 
in vitro grew when implanted into new hosts. 
Human.--Loeb et al (1912) began the use of 
colloidal copper in cases of hUman cancer in May, 1912. 
Their report, made in December, as well as one made early 
the following year, on nineteen cases treated with colloidal 
copper, noted improvement in most cases, especially those 
of slow growing tumors without too extensive metastases. 
No cures were claimed. McClurg, Sweek, Lyon, Fleisher, 
and Loeb (1915) treated a group of cases of non-keratizing 
cylindrical-celled cancer of the skin and a group of cases 
.. 
of squamous-celled cancer with their copper-casein prepar-
ation. Detailed case reports were given, but no cures 
of cases of proven malignancy were claimed. Weil (1913) 
treated twelve cases of cancer with colloidal copper, 
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eight of whieh completed the treatment; he stated that 
every improvement except destruction of the tumor oc-
curred, an 0. concluded that it is of no value in any case. 
Soiland, Costolow an~ Meland (1927) noted no effect in 
four cases treated by intramuscular injections of col-
loidal copper. 
SILVER. --Animal Tumors. --}Teuberg t Caspari, and Lohe (1912) 
found colloidal silver to be espeCially valuable in treat-
ment of transplantable and spontaneous tumors of mice. 
Silver preparations were marketed under the names of 
fulmargin and electrargol. Rohdenberg (1915) used colloidal 
silver and leci thin in phenol soluti. on to treat mice with 
the Ehrlich careinoma. His experiments were controlled 
with mice that were untreated as well as by those treated 
with silver and lecithin alone. One series showed slight 
benefit to all those treated over the untreated animals; 
variation in the percentage of the constituents had no 
effect. Treatment ha~ no effect whatever, however, on 
animals bearing the Croeker Fund mouse careinoma No.5. 
Walburn (1930) treated 130 miee bearing tar tumors with 
d51ute solutions of silver nitrate. There were fourteen 
eomplete regressions. 
Human.--No favorable results have been reported 
in the treatment of human cancer with silver preparations. 
Rohdenburg (1915) treated ten cases with colloidal silver 
and lecithin, all of which had had tissue diagnosis. All 
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the patients d.ied. Stone, Pack and Woodard (1930) used 
a preparation of colloidal silver prepared similarly to 
colloidal lead. There was no alteration in the course 
of the disease in the patients treated. 
BISMUTH.--Anir:1al Tumors.--Zadik (1930) claimed successful 
results in the treatment of a transplantable sarcoma of 
the rat with a bismuth preparation, Bismuth Yatren A, 
combined with isamine blue. Ishiwara (1927) found 
bismuth ammonium tartrate to be the only one of twenty 
metallic compounds successful in inhibiting the growth 
of the Flexner rat carcinoma. 
Human.--The success of Zadik in treating human 
cases with his mixture was reported at first as being only 
temporary. In a later report (1930) on the treatment of 
109 cases with isamine blue and bismuth (Wismut Yatren A, 
an or~anic acid containing bismuth and iodine), he claimed 
definite improvement in thirteen cases observed up to 
two years. Kahn and Wirth (1927) treated ten cases with 
colloidal bismuth (Wismut-Diasporal 360', in solutihon with 
d.extrose, and. X-ray. Their report at the end of a year 
claimed some beneficial results. Lasch and Neumann (1929) 
treated eighteen cases by Kahn's method, and noted an effect 
only in those cases in which X-ray was also used, but even 
here the results were poor. 
MAGNESIUl!.--Animal Tumors.--Delbet and Pallios (1928) claimed 
that transplantable tumors in an unstated number of mice 
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were retarded in growth by oral and subeutaneous adminis-
tration of magnesium compounds. Bolaffi (1930) treated. 
rats bearing an adenocarcinoma with magnesium chloride 
subcutaneously and orally and found only very slight 
prolongation of life as compared with controls and 
reduction of the size of the tumor in only certain instances. 
The magnesium content of the tumors was not altered, but 
the calcium to potassium ratio was increased in some 
instances. A later report (1930) on the use of magnesium 
iodide and magnes:!.um phosphate combined, or the latter 
alone, concluded that magnesium has no inhibitory effect 
on the growth of carcinoma of the rat and is of no value 
in treatment. Shear (1933) made an extensive revlew of 
the literature and carried on numerous experiments of his 
own ln a study of the role of magnesium in cancer, approaching 
the problem fro~ the standpoint of the content of the 
blood and the tumor of magnesium and the effect of its 
use in treatment. He concluded that there is some 
Question as to its value in the treatment of cancer but 
that the retarding effect claimed for it certainly does 
not exist, and that no points are sufficiently established 
to warrant clinical trial. Sugiura and Benedict (1935) 
studied the influen.ce of magnesium on the growth of car-
cinoma, sarcoma, and melanoma in animals. They found that 
aa.ministration of very low magnesium diets to animals after 
growth of transplantable tumors became established had 
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no marked inhibitory effect on the tumors, that very high 
magnesium diets slightly accelerated growth of tumors but 
that more regressions occurred, and that prolonged use 
of a high magnesium diet in animals with established 
F1exner-Job1ing rat carcinomas, mouse sarcoma 180 and 
the Passey mouse melanoma did not check the growth of the 
tumors. 
Human.--Schrumpf-Pierron (1931) believed that 
lack of intake of sufficient magnesium to be a cause of 
cancer. He attempted to show that cancer is about ten 
times as frequent in Europe as in Egypt and held that 
this is due to the fact that the soil of Egypt contains 
fj.fteen to seventeen times as much magnesium as that of 
France. Ernst (1932), however, was unable to report any 
cures among fifty-four patients treated by irradiation 
and a complex preparation containing magnesium. Craig 
(1934) used magnesium chloride with apparently good results 
in one case of carcinoma of the larynx observed over a 
period of only a few months. Cure was not claimed. 
Wright (1934) reported on four cases treated with mag-
nesium sulfate; benefit was thought to have resulted 
from the treatment but no cure was claimed. 
GOLD.--Anima1 Tumors.--Lewin (1913) used colloidal ~old, 
gold potassium cyanate and other gold salts in the treat-
ment of animals with malignant growths. There was some 
effect, which Lewin attributed to action on the young 
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capillaries of tu~ors, which he thought particularly 
easily injured. Fleisher and Loeb (1914) treated mice 
with carcinoma with colloidal gold and gold potassium 
cyanate, with little effect. 
Human.--Ochsner (1926) reported very favorably 
on the use of pure colloidal gold suspended in pure water 
in the treatment of cases of inoperable cancer. He 
gave case reports on five cases, one of which was alive 
and well after an interval of about four years. He 
sent questionaires to 182 physicians who had treated a 
total of 309 cases with colloidaJ gold. Six were reported 
cured and ninety-seven were too recent for opinion. Thus, 
out of 212 cases having sufficient treatment, six, or 
about three percent, were claimed cured. Soi1and, 
Costolow and Meland (1927) treated an unstated number of 
cases of inoperable cancer with colloidal gold by mouth 
with no effect. 
ANTIMONY.--There have been no reports on the use of th~s 
metal in animal tumors, but Minervini (1928) reported 
on the use of a combination of antimony tartrate and 
extract of ipecac root given by vein and intratumora1ly 
in cases of inoperable human cancer. At the time, he 
gave no results, but a later communication (1929) described 
th~ results in 141 cases of carcinoma and fourteen cases 
of sarcoma, all proven histologically. The preparation 
used was a solution of all the alkaloids of ipecacuanha 
wtth the addition of anitmony potassium tartrate, a pre-
paration he called Antiblastoma L. He discouraged the 
use of irradiation with this treatment. He claimed that 
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I in about one third of the cases arrest of the growth with 
decrease in size and sclerotization occurs. He has 
observed cases up to two years. Cestaro (1930) used 
Antiblastoma L in two cases and claimed one and two year 
cures. Pattarim (1931) found Minervini's preparation to 
be of no value in any of twenty cases. 
RADIOACTIVE ELEMENTS.--Animal Tumors.--Spies (1931) 
treated mice innoculated with the Twort carcinoma with 
uranium nitrate and thorium nitrate. The tumors grew 
faster in the forty treated animals than in the forty 
controls, due, Spies thought, to the stimulating effect 
of radioactive substances. Burrows (1934) treated rats 
bearing the Jensen sarcoma with a diverse group of sub-
stances, including thorium, gelatin, and alum. A higher 
percentage of retrogressions occurred in those treated 
by any method than in the untreated animals. The author 
believes this due to the fact that many things affect the 
host and result in reduced vigor of tumor growth, yet 
have no therapeutic value. He points out that conclusions 
based on the weight of the tumor are fallacj_ous, as 
well as those based solely upon grafted tumors. He con-
siders good results with the more reliable grafted tumors, 
such as the Crocker Fund mouse sarcoma 180, an indication 
for later use on spontaneous tumors before trying on 
human cases. 
Human.--Hocking (1928) used the feebly radio-
active substances uranium and thoriUm in an effort to 
combine the local effect of radium and the general effect 
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of lead and yet avoid the purely local action of radium 
and the toxic effect of lead. He treated thirty-one cases 
with these substances in colloidal solution and claimed 
improvement in seventy percent. One case of cancer of 
the breast with metastases is alive and well after 
twelve months. Pack and Stewart (1930) treated eight 
cases with Hocking's preparation in an effort to check 
his results. One was slightly benefitted but his life 
not prolonged, while the other seven were not benefitted 
in any way. 
MISCELLANEOUS METALS.--A number of metallic preparations 
enjoyed early popularity in the constitutional treatment 
of cancer but have since been shown to be without value 
or it has been discovered that the original results 
failed to establish any true value. Szecsi (193:2) found 
that a selentum-vanadium compound was the most active of 
the group of substances he employed in the treBtment of 
mice with transplantable tumors. Keysser (1914), however, 
showed that while superficial tumors were cured, the 
substance was entirely inactive in treatment of infil-
trating tUMors of the organs and that it had no effect 
upon the tumor cells in vitro. Neuberg, Caspari, and Lohe 
(1912) claimed success in the treatment of animal tumors 
with cobalt and with platinum, the latter having also been 
investigated by Fleisher and Loeb (1914). Kolmer (1926) 
included tin among those metals which had had early 
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popularity but which had no sUbstantial claim to effective-
ness. Krause (1929) investigated the effect of a group 
of complex organi c compound_s of tin on roi ce wi th ex-
perimental carcinoma to determ~_ne the toxici ty an(l chemo-
therapeutic effect. Regression of the tumor was noted 
in a small persentage of cases with two of the four 
compounds used. 
LeGuyon (1931) found potassium chromate, sodium 
chromate, chromium phosphate, and basic alumj_num acetate 
ineffective in treatment of the Jensen rat sarcoma. 
Ernst (1932) used a preparation containj_ng lithium, 
magnesium and iodine, called RIll, in the treatment of 
fifty-four cases; no cures were claimed. Engman (1932), 
thinking that thalllum acetate might affect young, actively 
growing cells, treated thirteen groups of five to fifteen 
rats each with the Flexner-Jobltng carcinoI!la in a well 
controlled eXT)6r4I!lent. No effect occurred. Lansbury (1932) 
used the sarle tumor ana. found no effect from thallium 
phosphate, acetate and iodide. Gardner (1928) had good 
results with titanium employing a compound derived from 
the action of titanium chloride on a lipase solution 
combined with sodium oleate. 
Shear (1933) made an extensive review of the 
role of potass5_um, sodium, calcium, and magnesium in 
cancer. He concluded that: sodium had no effect upon 
cancer, potassium may have a slight stimulating effect, 
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calcium possibly slightly retards the growth of cancer; 
the effect of magnesium has already been noted. In 
a later report, Shear (193'3) noted that he was unable to 
affect the tumor cells with calcium. 
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THE SPECIFIC CONSTIT1JTIONAL TREATl1iENT OF CAUCER 
IV 
ADDITIONAL INORGANIC COMPOUNDS 
SELENITTM.--Animal Tumors.--Selenium was the first sub-
stance to be used in the chemotherapt of cancer. 
Wassermann noted the staining of cells by eosin and com-
bined it with selenium in the hope that the toxic selenium 
would be carried to the malignant cells by the eosin. 
Experiments with the substance upon transplantable and 
sponmaneous rat tumors gave results which Wassermann 
considered suffictently successful to report at a meetine 
of the Berlin Medical Society (Wassermann, Keysser, and 
Wassermann, 1911). Following this report, there was wide 
comment upon the possibilities of the sUbstance (Editor-
ials, 1912). Wassermann, however, had made no great 
claims concerning the efficacy o~ his preparation, and 
his report failed to state the toxicity and the percentage 
of animals treated. succe ssfully. 
S00n a number of observers attempted to confirm 
this work. Uhlenhuth (1912), however, found that a group 
of compounds of selenium and various dyes had no effect 
on mouse and rat tumors, and Walker (1912) was unable to 
prepare an effective compound. Finally Keysser (1914), 
one of the partners in the original work reported by 
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Wassermann, founel that the substance cured only a very 
low percentage of animals, that it was very highly toxic, 
that it had no effect on such small tUmors as were not 
apt to undergo spontaneous central necrosis, that it had 
no effect on infiltrating tumors of organs or on metas-
tases, and, finally, that it was totally ineffective 
in destroying tumor cells in vitro. 
Human.--Following the early work on animals, 
several commercial selenium products were tested in 
cases of inoperable human cancer,--electro-se1enium, 
seleniol, sulpho-selene, etc. Results were reported by 
a number of observers, symptomattc improvement betng 
noted in the preliminary reDort of each in PloSt cases. 
Follow-up reports stating the final results in these 
cases, however, have never been published. Watson-
Williams (1919) sUffiTl",arized a group of these preliminary 
reports and was so favorably impressed that he employed 
a preparation called erythro-selenium beta in twenty-
four cases. He observed these a short time and listed 
improvements noted in nineteen cases, but he has not 
reported on their final outceme. 
After giving up the use of D43, a compound of 
lead and selenium, Tod.d (1934) investigated a number of 
selenium compounds not containing lead. He used two 
substances in each case of inoperable cancer treated 
since May, 1931. One was prepared from selenium dioxide 
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and colloidal sulfur, called SSe, and always followed 
its administration with irradiation, claiMing that 
the radient energy caused "ionizationf! of the SSe and 
thereby enhanced its value. The other substance, which 
was alternated with SSe, was selenium and SOMe feebly 
radioactive substances, radium G and traces of higher 
breakdown products, prepared to form a colloidal solution 
called R. A. S. This latter preparation produced regres-
sions in twenty-five percent of tumors in animals bearing 
a slow-growing strain of the Twort carcinoma. The first 
series consisted of ninety-three cases treated from May, 
1931 to September, 1932. Eighteen discontinued treatment, 
five were recent cases, three were cured but died of 
intercurrent disease, and fifteen are living and well and 
have been discharged as cured. The second series included 
all cases treated from Septernber, 1932 to date, numbering 
sixty-two in all. Twelve were recent cases, seven discon-
tinued treatment, three were discharged as cured., and nine 
were under treatment and doing very well, some awaiting 
discharge. There are, then, about twenty percent cures 
in each series. 
ARSENIC.--There are very few references to the use of 
arsenicals in the tre9tment of cancer. In view of its 
extensive use in the treatment of syphilis, this is 
difficult to explain. It seems probable that there were 
numerous early attempts to use arsenic in cancer but, 
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these beine failures, were not reported. 
Animal Tumors.--Uhlenhuth (1912) used a~number 
of arsenio preparations in the treatment of cancer in ani-
mals and found that stimulation of growth oocurred. 
Eggers (1934) investigated the effe·ot of compounds of 
arsenio and aoids derived from a group of hexose sugars 
on the FRC oarcinoma and the R39 rat sarcoma of the 
Crocker Institute. There haa been previous attempts by 
several observers to employ metabolic peculiarities of 
the cancer cells as a basis for chemotherapeutic attack. 
Eggers used the abnormal carbohydrate metabolism dis-
covered by Warburg (1931), by which an abnormal affinity 
or an altered mode of utilization of carbohydrates 
occurs in cancer cells. ~e employed sugars as carriers 
of toxic radicals in an effort to effect the elective 
intoxication of the cancer cells. While a compound 
containing a toxic redical attached to the side chain of 
the dextrose molecule would be theoretically best, there 
is no method at present of preparing such substance, so 
he was restricted to compounds of acids derived from 
sugars and tetramethyl arsonium as the toxic radical. 
Tetramethyl arsonium gluconate was the only suocessful 
oo~pound. In eleven rats with the FRC caroinoma, five 
tumors completely disappeared, while four of ten with the 
R39 tl'mor d j sappeared. Next insulin was administered wi th 
the arsenical to temporarily diminish the available 
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supply of glucose in the blood. Tumors in nine of twelve 
animals with small FRe tumors completely disappeared, 
while five of six slightly larger tumors disappeared. 
Tumors in twenty-one of twenty-two animals with small 
R39 tumors disappeared, while four of twelve larger ones 
disappeared. None disappeared when very large tumors 
were treated. The only regularity was with three day 
i~plants. The toxicity of the compound is very low. 
Human.--Dreuschuch and Lovas (1926) reported 
two cases of ovarian carcinoma treated by X-raY,!l group 
of hormones and an arsenic preparation, with both patients 
alive and well two years. Eggers has treated several 
cases of human inoperable cancer wtth tetramethyl 
arsonium gluconate, but he considers·the work too reeent 
for evaluation of results. 
SULFUR.--Animal Tumors.--Izar (1913) proposed colloidal 
sulfur for the treatment of trnplanted rat sarcoma. He 
found that rapid regression followed its intravenous use. 
Small tumors receded entirely, while large tumors became 
necrotic and deRth of the animal frequently followed, 
supposedly due to absorpti0n of the toxic material liber-
ated from the tumor cells. Zagni (1927) used a colloidal 
sulfur preparation called sulfosolo on a group of mice 
with experimental carcmnoma and sarcoma. Two of the 
sarcomas disappeared, and some success was claimed wlth 
the carcinoma, but :i.n no case was the total number of 
animals used given. 
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Human.--Cignozzi (1927) treated nearly one 
hundred cases with oral and intravenous administration of 
colloidal sulfur and noted some decrease in size of a 
few tumors. Surgical treatment and pre- or post-operative 
irradiation were combined in some cases. 
MISCELLANEOUS.--Tellurium, because of its similarity to 
selenium, has been used experimentally in the treatment 
of cancer. Wassermann, Keysser, and Wassermann (1911) 
seemed much less impressed of its value than that of 
selenium. Uhlenhuth (1912) found tellurium and iodine 
compounds to be of no value in treatment of rat and mouse 
tumors. Rossi (1928) believed sodium silicate necessary 
for cicatrization and sclerotization, and that when employed 
with other methods of treatment might be valuable in 
aiding the natural defense of the organism. The results 
of his use of this substance are inconclusive. Wog1om 
and Weber (1934) employed heavy water in doses equal to 
120 times the usual daily intake of heavy hydrogen, 
given subcutaneously, intraperitoneally, and intravenously 
saY-co"",'" in mice with .carcinoma 180 and carcinoma 63. There was 
no effect on the host or tumor. Ishiwara, Marsh, and 
Simpson and Marsh, in papers previously referred to, 
included the use of a number of the inorganic substances 
reviewed above in their work. 
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THE SPECIFIC COlfSTITUTIONAL TREAT1!ENT OF CANCER 
v 
ADDITIONAL ORGANIC COMPOUNDS 
Benedict and Lewis (1914) reported some success 
in treating experimental tumors with toxic doses of 
phloridzin. Wood and UcLean (1916) were unable to dupli-
cate their findings on mice with spontaneous mammary 
carcinoma, the Crocker Fund mouse sarcoma 180, and the 
Buffalo rat carcinoma using non-toxic doses of phloridzin. 
Results with the first two tumors were about the same in 
the treated animals as in the controls, while with the 
Buffalo rat sarcoma, fewer tumors in treated animals were 
absorbed than the untreatec. controls. Werner (1912) 
found rat tumors reduced in size after injection of 
choline borate subcutaneously. He later switched to a 
mixture containing choline borate, which was found to be 
entirely without value. Fleisher and Loeb (1914) exper-
imente<d. with casein, nucleoproteid, and hirudin, which 
they thought caused some inhibition of growth of the 
tumors employed. 
Karczag et al (1927) treated mice innoculated 
with the Ehrlich carcinoma with convulsive doses of 
potassium cyanide. They thought that this respiratory 
poison might have some selective effect on malignant 
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cells, based on the metabolic peculiarities discovered 
by Warburg. In ninety-eight m~ce treated, fourteen were 
cured, while none of forty-five untreated controls lived. 
:Maxwell ana. Bischoff (1933) tested hydrocyanic acid on 
several tumors of rats and mice. In several series of 
mice with sarcoma 180, the rate of growth in the seventy-
one controls was slightly greater than in the sixty treated 
animals. The rate of growth of tumors in rats with 
carcinoma 256 and sarcoma RIO appea.red to be slightly 
decreased. There were no significant differences in the 
number of takes and the number of regressions ~el1h.l'1delhn 
mice bearing sarcoma 180 between those treated with 
carbon monoxide and the untreated controls. Perry (1935) 
found that prolonged inhalation of cyanide arrests body 
growth in young rats and retards the growth of the Jensen 
rat sarcoma. While a considerable percentage showed 
complete regression, the compound was very toxic. 
A few of the amino acids have been tried. 
Vles and. his co-workers (1930) gave a mixture of alanine, 
cystine and proline to 107 mice with tar cancers following 
biopsy. Twenty-six disappeared, thirty-seven partially 
regressed, thirty-five remained stationary, and nine were 
unaffected. There were no regressions in forty-two con-
trols. A series of twenty mice were treated with a 
mixture containing two molecules of d-glutamic acid to 
one of cystine. Ten disappeared and six partially regressed. 
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In a later paper (1934), they reported on the use of 
amino acids (l-cystine, d-l-alanine, and d-I-proline) 
combined with dried powdered tissues. MRre mamIllary 
carcinomas regressed than when amino acids were used alone. 
Fifteen of the thirty-eight tumors disappeared. In another 
report, however, they stated that the cured animals 
died sooner than others, due to breakdown of tumor tissue. 
Gilroy (1930) found that a transplantable mouse tumor 
was unaffected by glycine, alanine, eystine, eysteine, 
glutamic acid, sodium valerate and histidine. Argenine 
stimulated growth. 
Marsh (1933) treated spontaneous Illouse carcinomas 
with ethyl alcohol by intraYenous, subeutaneous, and oral 
administration and by these methods in combination. 
None of the forty-niRe treated animals showed any curative 
effect. Nakahara (1924) found that while sodium oleate, 
oleic acid, linolic acid and linolenic acid increased the 
resistance of mice to subseq.uent innoculation wi th the 
Bashford adenoaarcinoma 63, there was no marked influence 
on established grafts. 
Krontowski et al (1932) attempted to inhibit 
glycolysis of tumor cells with monoiodoacetic acid and 
monobromacetic acid. These compounds were effective in 
vitro but failed to retard the growth of the Ehrlich 
mouse carcinoma or the Jensen rat sarcoma in intact 
animals in doses consistent with the effective concen-
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tration in vitro. Seele and Bodansky (1935) thought 
that similar substances having a greater permiability 
might be more effective. They treated rats bearing 
sarcoma 39 with relatively large doses of bromcaproic 
acid. Daily doses given for four weeks proved fatal 
to thirty to forty percent of the animals and had no 
specific inhibitory effect on the tumor. 
Amoroso (1935) treated mice bearing carcinoma 
63 with small quantities of colchicine. Two-thirds of 
the tumors of some series disappeared and all of those 
in other series regressed. An epithelioma of the buccal 
mucous membrane in a dog disappeared on treatment. 
DYES 
ISAMINE BLUE.--Animal Tumors.--This dye has been used by 
a nUJ!lber of experiMenters in the treatmen.t of inoperable 
human cancer since it was introduced by Roosen in 1923. 
Marsh and Simpson included it in a report on 145 coal 
tar dyes and their antecedents used in the treatment of 
albino house mice with spontaneous carcinoma of the 
breast. Practically every dye ever used to treat cancer 
is included in the list, and none subsequently mentioned 
in this paper were omitted. The results were uniformly 
entirely negative. Zadik (1930) claimed success in the 
treatment of transplantable rat carcinoma with pure 
isamine blue and bismuth. 
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Human.--Roosen (1923) observed some concentration 
of isamine blue in tumors. He argued that since the dye 
is very easily reduced in the body, injection of some 
very easily exidizable substance following administration 
of the dye might lead to formation of deleterious substances, 
in the tumor cell. The easily oxidizable substance 
selected was neosalvarsan. The two were administered 
alternately at intervals of several days. The author claims 
good results, especially on small skin cancers. Sarcoma 
were found more susceptible than carcinoma. Internal 
tumors responded poorly. Irradiation destroyed the power 
of the tumor of absorbing the dye. Bernhardt, and Bern-
hardt and Strauch (1928) reported on eighteen cases 
treated with isamine blue. Five regressed, ten improved, 
and eight were not i~proved. Roosen, in 1930, advocated 
isamine blue alone rather than combined with bismuth 
ot irradiation, and has published a book summarizing the 
work done by a group of observers. Karrenberg (1929) 
had no regressions in five cases, and ZadikTs results 
on human cases were only temporary. Nyka (1931) included 
isamine blue in a review of nine dyes used in the treat-
ment of cancer and concluded that it was of doubtful 
value. 
MISCELLANEOUS DYES.--Copeman (1928) reported on five 
cases of inoperable carcinoma of the breast, one of which 
completely disappeared under treatment by "activated" 
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flourescein. His idea was that administration of the dye 
followed by irradiation of the tumor produced an especially 
great effect effect on the tumor because of the effect 
of the irradiation on the dye. A later report on seventy 
cases was made by Copeman, Coke and Gouldesbrough (1929) 
and a final one by Copeman (1931) on 120 cases. Twenty-
three of these apparently recovered. Mottram (1929) 
tested the effect of flourescein and irradiation on 
tumor tissue in vitro. He found that the action was 
purely a summation of the effects of the flourescein and 
irrad.ia ti on. 
Rossi (1928) included methylene blue with 
sodium silicate and magnesium sulfate in the treatment 
of inoperable tumors. The results are inconclusive and 
the value of the incltvidual substances impossible to 
determjne. Sugiura and Benedict (1929) studied the 
toxic action in vitro of malachite green, methylene blue, 
gentian violet and congo red on the Flexner-Jobling rat 
carcinoma, the Sugiura rat sarcoma and the Rous chicken 
sarcoma. While of some value, in the order listed, the 
authors did not seem ~articular1y impressed. 
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THE SPEC IPIC CONSTITUTIONAL TREATMENT OF CAJ'TCBR 
VI 
BIOLOGICAL PREPARATIONS 
A. HORMONES AND TISSUE EXTRACTS 
EXTRACTS OF THE SUPRARENAL GLANDS.--Anatomic and functional 
differences between the cortex and medulla of the supra-
renal gland are now well established. While most prepar-
ations used in the treatment of cancer have been cortical 
extracts, some have used medullary extract and others 
mixtures. Coffey and Humber, whose much publicized work 
opened the controversy on the value of suprarenal cortex 
extract in the treatment of cancer, hate published several 
reports (1930, 1931) on their work. It was based on the 
theory that the normal secretion of these structu~es 
controls tissue growth and can destroy malignant tissue. 
As far as it has been possible to determine, however, 
Coffey and Humber have at no time reported the number of 
cases treated, giving the information necessary for deter-
mining the percentage of cures, not have they given the 
basis'they fave used for considering a case cured. In-
asmuch as the reports by the originators of this method 
of treatment is concerned, then, there is no evidence of 
its value. 
Animal Tumors.~-Bischoff and Maxwell (1930, 1931) 
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employed eight preparations of suprarenal extract, including 
that of Coffey and Humber, on rats with sarcoma 10 and 
the Hyde carcinoma and found all to be without effect on 
the indidence of regressions and the rate of growth of 
the tumors. Woglom (1931) treated mice bearing carcinoma 
63 and sarcoma lBO with suprarenal extract taken from 
rabbits treated with mouse tumor extracts and with a 
preparation from normal rabbits. There was no inhibitory 
effect. Sugiura (1931) used an aqueous extract of sheep 
suprarenal cortex prepareo. by the methed of Coffey and 
Humber tn the treatment of animals with the Flexner-
Jobling rat carcinoma, the Sugiura rat carcinoma, the 
Bashford mouse carcinoma 63, a transplantable mouse 
melanoma, and Rous chicken sarcoma, and spontaneous 
mammary carcinoma of the mouse. Subsutaneous and 
intramuscular, single and repeated injections had no 
curative, retarding or accelerating effect on the growth 
of the tumor or on the duration of life of the animal. 
Itami and McDonald (1930) could observe no effect on a 
spontaneous mouse tumor from the preparation they used. 
Reicher (1910) claimed adrenal in injected intra-
tumorally destroyed mouse carcinoma and rat sarcoma, 
while Uhlenhuth (1910) had found no therapeutic effect. 
Lumsden (1931) used it with a serum injection to prevent 
absorption of the serum. Tamura (1934) treated rats 
bearing the Flexner-Jobling carcinoma and rabbits bearing 
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the Kato sarcoma with a variety of extracts of the supra-
renal gland. Large doses of the cortical preparatj.on 
were slightly inhibitory, while adrenal in produced 
distinct transitory acceleration of growth. Sugiura 
and Benedict (1930) investigated the effect of suprarenal 
extract upon the Flexner-Jobling rat carcinoma and the 
Rous chicken sarcoma. They studied the effect of intra-
tumoral injection, distal subsutaneous tnjection and 
application to the tumor cells in vitro. They found that 
intratumoral injection injibits small tumors completely 
but has no effect on larger ones; that remote subeutaneous 
injection has no effect, and that the Flexner-Jobling tumor 
is partially destroyed and the Rous sarcoma unaffected 
by application in vitro. They concluded that any possible 
value was limited to intratumoral injection. 
Human.--Naame (1929) treated a group of patients 
w:I th thyroid , liver and suprarenal extracts. He referred 
to six cases, two of which were clajmed cured. M. Roussy, 
in dtsctlssion, stated that no effect hall been produced 
in any case he treated. Livsic (1932) held that suprarenal 
cortex is employed in the defense against cancer by way 
of regulating lipoid metabolism, and he employed extracts 
thereof in the treatment of human cases. He gives reports 
on two cases that were apparently benefttted. Dominguez 
(1931) treated thirteen patients with adrenal in and sppra-
renal products especially prepared and noted no improvement 
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in any case. Harris (1931) undertook a clinical study of 
415 cases with malignant tumors who had received experi-
mental injection of the Goffey-Humber extract. There 
were 264 known dead in fourteen months; of the remainder, 
there was no evidence of any cures. Ball (1931) per-
formed autopsies on 116 cases of malignant disease, 
eighty-nine of which had received experimental injections 
of the Coffey-Humber extract. No essential change from 
that usually observed in the characteristics of malignant 
disease in far advanced cases could be found in the tissues 
of the eighty-nine cases treated. 
PITUITARY AND OVARIAN HORMONES.--Animal Tumors.--A group 
of Japanese investigators (Murohara, Motsuoka, Maeda, 
and Bimento, 1930) found that the rate of growth of a 
transplantable rabbit sarcoma was retarded and the inci-
dence of metastases reduced by the administration of 
follicular fluid. They reported the same results from 
large doses of thyroxin in potassium iodide ano from 
thymoglandol. Bischoff and Maxwell (1930), however, 
treated rats with sarcoma 10 with the Alan-Doisy folli-
cular preparation, corpus 1uteum extract, and three 
splenic extracts without effect on the incidence of 
regressions or the rate of growth in well controlled 
experiments. Later (1931), they reported on the use of 
placental and pregnant urine e~tracts, thyroxin, synthalin 
and parathormone on rats with sarcoma 10. All these 
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substances were ineffective. Gruhzit (1933) treated rats 
which had been innoculated with the Flexner-Jobling 
carcinoma with anterior pituitary hormone extracted from 
the urine of pregnant women. There was no significant 
difference in the course of the disease in the 124 treated 
animals and the 110 controls. Gross (1932) used extracts 
of urine of pre~ant women and urine of women having 
cancer, hormones of the anterior pituitary, human and 
bovine placenta, and umbilical cord extracts on 321 mice 
having the Vienna sarcoma. There were no consistent 
specific results. In 1933, Maxwell and Bischoff treated 
fourteen mice bearing the sarcoma 180 with pituitrin, 
and noted no difference in the rate of growth in the 
treated animals anc in the fifteen controls. Krehbiel, 
Haagensen, and Plantenga (1934) treated sixty animals 
who had been inoculated with mouse sarcoma 180 with an 
anterior pituitary hormone. Forty-five died during the 
period of observation of the experiment, and there was 
no evidence of improvement in the fifteen survivors. 
Tanzer (1936) reviewed much of the work done on the use 
of hormones in the treatment of cancer and called atten-
tion to hazards arising from the difficulties of differ-
entiating direct and indirect effects. The indirect ef-
fects consist of malnutrition and sickness of animals. 
To eliminate such hazards, he set up experiments in which 
the tumor tissue was ex:t3osed directly to prolan extract 
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in vitro, following which inoculation was made into the 
host and a control inoculated into the same animal. He 
used follutein, a powdered prolan prepared by the method 
of Aschheim and Zondek and mouse sarcoma 180 and S37. 
Nith the former, there was no evidence of inhibition or 
acciteration of growth, while with the latter, there was 
slight inhibition of growth. 
HUI!lan.--Susman (1931) postulated some increased 
secretion of the anterior pituitary in cases of malignant 
disease and sought to reduce this with pituitrin and 
theelin. Since abundant carbohydrate in the diet of 
mice promoted the development of irritation c~r~inoma, 
the carbohydrate intake was restricted. Reports on seven 
treated cases claim some improvement during the short 
period of observation. Ishihara (1934) was convinced 
that Wharton's jelly was an important structure, having 
an endocrine function, and that a similar hormone is to 
be found in the jelly between the inner and_ outer egg 
integuments of the placenta and in the corpus luteum of 
the ovary. He reported on the use of this substance, 
which he called "P. O. U.ry (placenta-ovary-umbilicus) 
hormone, in more than 200 cases, many of which appeared 
cured. Several have not relapsed in three years. A 
number of case reports are given. Stewart (1932) gave 
case reports on four patients treated with pituitary 




Kremer (1932) treated nine cases by the method of Susman, 
all their cases following the 'fumal course of the disease 
with no regressions or prolongation of life. 
MISCELLA}I~EOUS. --Cioffari and :?iccaluga (1926) treated 
mice before, after, ana before and after inoculation 
with a tumor with insulin. Those treated both before 
and after inoculation showed some retardation of growth 
of the tumor, living ten to fifteen days longer than the 
other animals. No regressions occurred. Boivin (1927) 
treated one rabbit with tar cancer with insulin without 
beneficial effect. Fichera (1933) beleived cancer due 
to a disturbance of the tissues and organs which regulate 
cytolysis and sought to cure it by administration of a 
preparation containing extracts of the organs he found 
to increase cytolysis. He c8~led this method "lytic 
regulating organotherapy". Over 300 cases have been treated 
of which over 100 were inoperable and ray-resistant cases 
with recurrences Rnd metastases. Using only the bi~-
logic oncolytic regulating therapy, complete regressions 
occurred in nine percent of the aases and permanent 
stand-still of the tumor growth was observed in eight 
percent. Schulte and Lutteken (1935) treated sixty-one 
patients by FicheraTs method nnd found none in any way 
improved. They comment that this is the usual finding 
of all except Fichera. Konsuloff (1934) treated mice 
bearing the Ehrlich tumor with a mixture prepared from 
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a splenic extract and alkaline earth metals. Of the 120 
mice treated, slowing of growth occurred in fifty to eighty 
percent. As the computed volumes varied greatly in the 
treated animals and in the controls, they wisely refrained 
from reaching any definite conclusions from their results. 
Stmpson and Marsh (1931) found karkino1ysin, a thymic 
extract, to be without value in the treatment of a spon-
taneous mamMary carcinoma of the mouse. Rohdenburg and 
Bullock (1915) noted that insufficient or exoessive 
secretion of the thyroid, thymus, ovary, adrenal and 
pancreas had been thought causes of cancer, and extracts 
of these glands used in treatment. They reasoned that 
if functional changes are accompanied by histologic 
changes, controlled observation of the histoloty of these 
glands in animals bearing spontaneous tumors might throw 
some light on their role in the cause and cure of cancer. 
As a result of this line of thought, they examined the 
liver, kidney, spleen, pancreas, ovary, thymus, pituitary, 
parathyroid, thyroid, and adrenal of mice with spontaneous 
tumors and of controls. Their was no signiflcant differ-
ence In these organs in the affected anlmals and the con-
trols. Maisln and Pourboix (1935) reviewed the history 
of work with growth-promoting and. growth-inhi bi ting 
substances extracted from normal organs. 
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B. VENOl.dS 
It has been established that the venoms of some 
snakes have an analgesic action when administered in 
proper doses to cancer patients. The value of this 
method of producing analgesia as compared with the more 
standard procedures is disputed. Many papers have been 
published on this ~atter with no reference to cure of 
cancer, but as it was introduced as a method of cure, 
there have been numerous reports seeking to establish its 
value therein. Only those dealing with the latter phase 
of the subject will be considered here. Attention 
should be called, however, to the fact that besides the 
negative reports, the many instances in which it has been 
used as an analgesic without cure resulting detracts 
from the possibility of its having any curative value. 
Animal Tumors.--Essex antt Priestly (1931) 
investj.gated the effect of rattle snake venom on the 
Flexner-Jobling rat carcinoma and. founel it to be of no 
curative value. Grasset and dse I,egneri s (1934) found 
no constant inhibitory effect in vivo or in vitro on the 
Rous chicken sarcoma. The transitory effect on melanomas 
in an Angora goat and a horse were not maintained, perhaps 
because an anti venom was produced. 
Human.--Piton (1934) treated fifty cases with 
only partial relief of pain and occasional transitory 
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arrest of the growth. He points out that Professor 
Billard, in about 1913, claimed success in treatment of 
one nase of carcinoma with viper venom. Lavedan (1935) 
treated fifty-one cases of histologically c')nfirmed 
cancer with cobra venom. Some cases received intramuscular 
injections, while others were treated by injection directly 
into the tumor. From his results as well as from those 
of others whose work he revfuews he concludes that the 
relief from pain is irregular and inconstant, mapy 
patients experiencing no relief at all; that the action 
on tumors in man is nil; and that under these cond:itions, 
its use should be reserved for the rare cases in which 
morphine is ineffectual. 
C. BACTERIA AND TT{EIR GROWTH PRODUCTS 
It had long been noted that patients with cancer 
were often improved markedly following an attack of an 
acute febrile disease, especially erysipelas. Many of 
the cases in which spontaneous regression of established 
neoplasms had been reported had given a history of such 
attacks of febrile disease. Fehleisen (1883) discovered 
and proved the etiology of erysipelas and inoculated 
seven patients having advanced and hopeless cancers with 
Streptococcus erysipelas. Of the six in which the disease 
developed, the neoplasm became much improved jn three. 
This is the earliest available record of the use of 
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specific constitutional methods of treatment of cancer 
in modern times. Lassar used sterile filtrates of 
Streptococcus erysipelas cultures in the attempt to treat 
human malignant disease in 1891. At the time, the 
method had not been placed 1J.pon an experimental basis, 
but soon afterwards Spronck (1892) treated animals bearing 
spontaneous neoplasms with killed cultures. While the 
results of these early works were not especially good, 
they led others, notably Coley, to investigate this field. 
Animal Tumors.--Spronck (1892) treated animals 
bearing spontaneous tumors with killed cultures of 
Streptococcus erysipelas. He considered the results in 
a few cases encouraging. Beebe and Tracy (1907) made 
multiple inoculations of a transplantable lymphosarcoma 
iEma eleven dogs. Both the sterile culture and the fil-
trate of Staphylococcus pyogenes aureus, Streptococcus 
pyogenes, Bacillus prodigiosus, and Bacillus coli com-
munis were used intratumorally and by injection distal 
to the tumors. Some of the tumors regressed partially 
and there were some complete recessions. Then, for a 
long peri0d during which Coley's toxins were betng used 
in a few human cases, interest tn the experimental aspect 
of this subject lagged, until revived in 1931 by the 
work of Gratia and Linz. 
They treated transplanted liposarcoma of the 
guinea pig with filtrates of Bacillus coli and obtained 
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hemorrhage and liquefaction in some tumors. Shwartzman 
had noted a skin reaction to meningococcus filtrate in 
a large percent of animals bearing neoplasms, which he 
considered of value as a serological method of diagnosis 
of cancer. In 1932, he (Shwartzman and Michailovsky) 
reported some complete regressions of mouse sarcoma 180 
following administration of meningococcus filtrate. 
Later (1935), he studied the effect of spontaneous and 
induced infection on the development of mouse sarcoma 
180. Bacillus enteriditis infection in 610 mice prevented 
the occurrence of growth of inoculated neoplasm in 
twenty-three percent of the animals at the end of the 
second week. Staphylococcus aureus was of no value, but 
Bacillus enteriditis (rough) caused complete regression 
of the tumor in eight of twenty aniMals. Staphylococcus 
aureus culture filtrate was also inacti~e, but the sterile 
filtrate of a culture of Bacillus enteriditis gave results 
similar to those of the live organism. Shear (1935), after 
studying a very large group of chemicals in the treatment 
of cancer, c!mcluded that his best results were wlth 
badterial filtrates. He tested agar washings of menin-
gococcus filtrates with results which he considered 
encouraging, a few of the growths completely and perman-
ently receeding. He stated that other experiments which 
were soon to be reported had given favorable results in 
upward to 100% of the treated animals. Duran-Reynals 
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(1933) undertook the study of the reaction of tumors to 
blood carried bacterial toxins. With Bacillus coli 
toxins he found rapidly growing transplantable malignant 
tumors of rats and mice to be susceptible, while slow 
growing were not. Later (1935), he treated fifty-two 
mice bearing proven mammary carcinoma with very toxic 
agar washings of human or mouse typhoid bacilli or both. 
Six were entirely inhibited, three cured and three 
recurred. Results were better in small tumors than in 
large ones. 
Torrey and Kahn (1927) used the proteolytic 
enzymes of Bacillus sporogenes and Bacillus histolyticus 
to treat white rats inoculated with the Flexner-Jobling 
carcinoma. The former was dropped because of the un-
satisfactory results obtained. Use of the live Bacillus 
histolyticus contained in whole broth cultures caused 
very energetic digestion which was not li~ited to the 
tumor. In their attempts to prepare a satisfactory 
sterile filtrate, they Modified the medium, culture 
method, and concentration of the proteolytic ferment. 
Their best results were with a certain strain of the 
organism grown for twenty-four hours on a three to four 
percent peptone meat infusion broth by the Huntoon method 
with added fresh defibrinated blood, especially where a 
few living organisms were added. Fifty to seventy-five 
percent were cured where the skin was not too much in-
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volved. As the injections were intratumoral, however, 
the method does not lall clearly into the field of 
constitutional treatment. 
Spontaneous mammary carcinoma of the mouse 
were not benefitted by Tuberculin (Simpson and Marsh, 
1931). Gye (1935) used ensol (see Connell, below) on 
appropriate mice and found it to be worthless. Roskin 
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and Monanowa (1935) experimented with the use of several 
protozoan infections in the treatment of tumors of 
animals. They found that infection with Spironema duttoni 
or treatment with baoterial endotoxins ("pyrifer", from 
non-pathogens of the coli type) had no effect on an 
unspecified type of transplantable mouse carcinoma, and 
that Trypanosoma equiperdum was ineffective against an 
unidentified guinea pig tumor. Infection with Schizo-
trypanum cruzi and injection withe the sterile endotoxin 
retarded the growth of the ~ouse tumor. Forty-five mice 
were simultaneously inoculated with the tumor and infected 
with the organism; thirty growths disappeared and fifteen 
were retarded in growth but all the animals subsequently 
died of the infection. Forty animals were treated with 
the endotoxins alone; twenty-four grew and of these the 
rate of growth was considerably smaller in the treated 
group than in the controls. 
HUMan.--Lassar (1891) was not impressed by the 
results he attained in the treatment of two cases of 
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human cancer with sterilt:f filtrates of Streptococcus 
erysipelas. Coley (1891), however, noting the obser-
vations of others regarding the results of accidental 
ot deliberate production of erysipelas in cancer p~tients, 
treated several such patients by inoculation with the 
disease and. considered his results sufficiently good to 
warrent further trial. By 1893, he had collected records 
of forty-seven cases of cancer patients (ten of which 
were personal cases) that had been accidentally or 
deliberately inoculated with Streptococcus erysipelas. 
He concluded that the curative effect in some cases was 
an established fact; that sarcoma Patients were more 
often benefitted than carcinoma patients, in a ratio of 
about three to one; that the treatment was not dangerous; 
and that the effect was due to the systemic action of 
the toxins of the organism. A note appended to this 
article stated that the toxins of the organism combined 
with those of Bacillus prodigiosus were being tried and 
would be reported soon. This latter combination became 
known as Co~eyTs toxins. Seyeral reports were made in 
the following years by Coley as well as by a number of 
other physicians who had tried the Coley treatment. 
While some denied any value whatever in the method, 
the majority found that the treatment was of some benefit 
in a small percentage of cases. Coley reported on the 
late results in his ear!~ Buceessful cases as we&l as on 
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the successful cases reported in the literature by 1906. 
Twenty-four of Coley's cases were living and well three 
to thirteen years, and twenty-seven cases of other 
physicians were living and well three to twelve years. 
At the time, only sarcoma were considered sufficiently 
benefitted to warrent treatment. Coley's toxins were 
admitted to New and Uon-official Remedies in 1910. The 
council's report stated that four to nine percent of the 
cases treated were cured. The product was reconsidered 
and retained by the council in 1934 following consideration 
of numerous pro and con reports on its value. The council 
concluded that use of the mixed toxins may prevGnt or 
retard recurrences or metastases, that an occasional 
cure may result in an otherwise hopeless case, and that 
the value is probably limited to tumors of entodermal or 
mesodermal dirivation, especially bone tumors without 
marked osteoplasia. Coley's later reports (1927, 1928, 
1931) dealt for the most part with bone tumors. His 
results show that irradiation or amputation alone cannot 
be expected to cure cases of bone sarcoma, but that 
toxins and amputation cure a large percent of cases 
including many in which new bone formation occurs, that 
the toxins and irradiatj.on cure some cases in which new 
bone formation does not occur, and that toxins alone 
have cured a few cases. The case of Christian and Palmer 
(192 7 , 1928) is an example of a recurrent myelosarcoma 
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(endothelial myeloma?) successfully treated by toxins 
alone. Campbell (1935) analysed a group of 125 patients 
with pri~ary malignant bone tumors, fourteen of which were 
living and well five years or more. Ten were osteogenic 
sarcoma and four were non-osteogenic. Coley's toxins 
were used in four cases,--one case of vary malignant 
osteogenic sarcoma was living and well four and one 
haif years following amputation and toxins; three cases 
of endothelial myeloma (Ewing's tumor) were living and 
well four, five and eight ya,ars following treatMent with 
Coley's toxins combined in each case wlth amputation, 
irradiation, or both. 
Coley (1928) reported the end results in the 
treatment of thirty-nine cases of Hodgkin's disease 
and fifty-eight cases of lymphosarcoma, where the mixed 
toxins alone or the toxins combined wjth irradiation were 
used. Three of the former and six of the latter were in 
good health three or more years. 
Connell (1935) treated a group of animals and 
patients with a solution prepared as a filtrate of the 
growth products of Bacillus histolyticus grown on cancer 
tissue of the same type as the growth to be treated. 
Although the statistics were not given and the period of 
observation was short, the author concluded that the 
substance was valuable. He called it ftensol lf (enzyme 
solution). Pearl, Sutton and Howard (1929) treated 
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seven cases wi th subcru:traneous injections of tuberculin. 
They thought the size of the t"nmors to be reduced and the 
life of the patients prolonged, but claimed no cures. 
D. MISCELLAi~EOUS 
Whitehouse (1927) reported a case of ovarian 
carcinoma with peritoneal metastases treated by trans-
fusion of blood of a woman ten weeks pregnant and trans-
fusion of irradiated ascitic fluid. Intensive regression 
followed. Dziembowski (1930) treated 120 patients by 
injecting irradiated autogenous blood into the tumor and 
intravenously. At the time the results were not discussed, 
but in a later report (1931), cures were claimed in a 
few cases. Hyde (1935) reported on the use of irradiated 
autogenous blood in advanced cases of cancer following 
incomplete extirpation of the growth. The injection is 
made intravenously after irradiation of the blood. The 
number of cases treated was not given nor were the number 
of cures, but the author refers to several cases greatly 
benefitted. 
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THE SPECIFIC CONSTITUTIONAL TREATMENT OF CANCER 
VII 
MISCELLA1TEOUS :METHODS 
FEVER TRERAPY.--The classification of certain methods of 
treatment of cancer presents so~e difficulties because 
simil~r methods differ in the theories of their action. 
Thus, methods will be included here that may seem to 
belong elsewhere, but the substances herein reviewed 
are arbitrarily classified, for the most part, according 
to the theory of action advanced by the various indiv-
dual investigators. ·n no case, however, is a single 
substance or method considered under two topics because 
of differences in the theories of acti0n advanced. 
Animal Tumors.--Rohdenburg and Prime (1921) 
studied the effects of combined heat and radiation on 
transplantable tumors in vitro and on spontaneous tumors 
in vivo. They found that low degrees of heat continued 
sufficiently mong were 100% effective in killing cancer 
cells in vitr~nd that heat combined with irradiation 
---\ 
extended the usefulness of the latter. They note that 
reports on fever treatment of malignant tumors had been 
made years previous by Loeb, 1912; Jensen, 1903; and 
Clowes, 1906. Woglom followed this with a study of body 
temperature and tumor growth in 1924, but because the 
results were negative, they were not reported until 1934, 
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by which time some favorable reports had accumulated. 
Woglom investigated the effect of febrile temperatures 
on seventy-seven rats with the Flexner-Job1ing carcinoma 
or the Jensen sarcoma and on thirty-nine mice with car-
cinoma 63 or sarcoma 180. Eighteen experiments were 
performed in which different temperatures and different 
exposure times, varying from thirty-one to a total of 
348 hours, were employed. No adverse effect upon the 
tumor was noted in any case. WaD::er (1935), who had 
previously found that eXDosure of rat tumor 256 to a 
temperature of 111.40 in vitro uniformly prevented takes 
on subsequent implantation, kept twenty-six animals at 
that temperature for twenty minutes. The tumors from 
each of the six rats that survived the twenty minutes 
(but which died within eight hours) were implanted into 
eight rats at the time of the death of the animal While 
controls grew in each instance, only two of the forty-eight 
treated tumors grew. Thirty minutes at 109 0 four ti~es 
had no effect on the tumor. When the temperature was 
maintained at 111.40 by means of a high frequency appar-
atus, none of the thirty-:ftve animals survived twenty 
minutes. :?racttcally all of the tumors had been devi tal-
ized at the time of the death of the animal as noted by 
failure to take on implantation. 
Human.--Braunstein (1931) inoculated six patients 
with the tertian malarial parasite and noted distinct but 
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transient regression of the tumor. Warren (1935) under-
took a rather extensive study of the effect of artificial 
fever on hopeless tumor cases. He studied the effects 
of febrile temperature on animal tUmors in vitro and 
l~ vivo; the temperature gradient during local and general 
heating; and the effects of prolonged and mainta:i.ned 
generalized artificial fever in hopeless tlli~or cases with 
metastases. His in vitro experiments showed that there 
is a definite lethal time-temperature for malignant tissue 
as there is for the gonococcus and the Treponema pallidum. 
Animals di.d not endure the necessary temperature for the 
time indicated by the in vitro experiments to be the 
thermal death time. In h5.s human cases, he first used 
diathermy and later radient energy, raising the temperature 
to 41.5 0 • Of the thirty-two cases treated, thirty were 
proven malignancy. The obseFvatj.on period extended 
twenty-three months, and all but three relatively recent 
cases had died., with one exception, within thirteen months. 
Doux (1935) reported a case of proven osteogenic sarcoma 
of the clavicle hiving deep X-rRY and eight fever tre.at-
~ents at weekly intervals, at which times the rectal 
~ 
temperature was maintained at 105-106 0 for five hours. 
Steady and continnnus improvement ensued and the patient 
was working and aDparently well at the end of an observa-
tion period of slightly more than a year. In discussion, 
Dr. Bierman stated that a case of cancer of the lung was 
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alive three years following fever therapy. 
A book published by Wiley Meyer in 1931 is 
interesting from the standpoint of fever therapy in cancer, 
but as no new experimental work is presented, it is not 
discussed here. 
GASES.--Campbell (1931) makes a critical review of the 
use of gas mixtures in cancer therapy. Inhalation of 
gas containing a high percentage of oxygen as recommended 
by Campbell and Cramer; increased atmospheric pressure 
studied by Fischer and 5% carbon dioxide in oxygen re-
ported by Fischer-Wasels as well as a number of others 
were reviewed. He concludes that there is no evidence 
of any influence on tumors or their metastases. DeAlmeida 
(1934) treated rats bearing the Raffo sarcoma. Seven 
to twenty-three percent of the an:i'"'1als we.Fe cured by 
oxygen at one to eight atmospheres treated at twenty 
minute to twenty-four hour intervals. SOMe tumors were 
co~'letely destroyed, but there was a heavy mortality 
in the treated animals. 
WATER BALANCE.--Shear has undertaken a number of funda-
mental studies of the chemistry of tumors with view to 
discovering' a method of chem;cal treamment. Reference 
has already been made to his studies of the role of 
sodtum, potassium, calcium, and magnesium in cancer and 
to the findings as to the effect of bacterial filtrates. 
The latter study (1935) was part of an investigation of 
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disturbances of fluid exchange on transplantable mouse 
tumors. Fe hael studied such matters in in vi tro exper-
iments (Shear and Fogg, 1934) and the present paper 
reports results of tests of the methods in vivo on mice 
bearing sarcoma 180 or carcinoma 63. His results with 
deprivation of water, use of diuretics and massive 
bleeQing were negative, so he attempted to alter the 
permiability of the cancer cells. To do this, the following 
substances were administered with the results noted: 
histamine, tyramine, trimethylamine, indole, skatol and 
choline with negative results; pneumococcus anltbody 
and soluble specific carbohydrate, with some effect--
hemorrhage; bacterial filtrates, as have been noted, with 
striking results; lipoid solvents !iI,neluding alcohol, 
ether, chloroform, carbon tetrachloride, bile salts, 
and lecithin with negative results; sodium oleate with 
some effect; fibrin, sodium citrate and heparin with 
negative results; high protein diets and injection of 
agar, acacia, altg albumen, and serum albumen caused a few 
recessions; repeated horse serum injections into seventeen 
animals caused three complete recessions. The author ad-
mitted that many of the substances used here may have 
actions whtch are not entirely depeno_ent on their effect 
on fluid exchange, but he considered this the most im-
portant action of each for reasons given. 
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VIII 
DISCUSSION 
It seems desirable to discuss the substances 
and ~ethods reviewed in an atte~pt to estimate their 
value. But before entering into a discussion of the 
individual sUbstances employed. certain facts must be 
pointed out. 
Essential data are not given in many reports, 
making it impossible to evaluate substances in the light 
of any preconcieved criteria, such as those of Weil or 
of the health organization of the JJeague of Nations. 
But of the manY'::'1substances considered, by far the largest 
share can be dismissed without detailed analysis because 
of glaring lack of adequate scientific evidence of ef-
fectiveness. In such cases, we must take the attitude 
that S substance is of no value unJess proven so by 
scientific observations, that is, the burden of proof 
rests with those claiming effectiveness. 
The significance of negative results is impor-
tant. Where such results with identical compounds are 
overwhelming, especially where there have been few 
positive results reported or where the previous reports 
have arrived at positive conclusions without justification, 
we must conclude that the SUbstance is without value. 
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However, as has been pointed out by Marsh and Si~pson, 
negative results with a single compound of an elemant 
and under a narrow range of experimental conditions 
do not establish the lack of value of that element, 
for variation of the compounds used or of the details 
of the experi~ent might yield different results. Thus, 
conclusions must be limited to the circumstances of the 
experiment, except inasmuch as they yield suggestions 
for other possible useful experiments. 
The purpose of all work on methods of con-
sti tutional i;reatment of cancer is to dj.scover a substance 
that may be used successfully in human cases, thereby 
reaching beyond the present limits of surgery and ir-
radiation. Successful results with animal experiments 
are, the~efore, valuable as leads, pointing to those 
substances which may prove of value in human cases. 
This useful aid makes possible the investigation of a 
great many substances and should be employed in every 
case before human material is used. 
Of the me.tallic preparations, lead and gold 
seem to merit consideration. While most of the animal 
experiments with lead compounds have been negative, 
the results of Collier and Krause with complex organic 
compounds of lead are moderately successful and further 
work with them is indicated. The principal claims are 
made for lead in the clinical field, much work having 
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been done with human subjects. All that can be said is 
that some observers have reported five to ten percent 
cures in otherwise hopeless cases, while others have 
been unable to note any useful results whatever. One 
can hardly reach any conclusions as to-its value is view 
of such markedly conflicting reports, and further work 
is indicated, probably using some compound whose effective-
ness can be established by animal,experimentation. 
No favorable experimental work haA been done on gold, 
but in view of fichsner's reports of human cases, further 
work should be undertaken. The results with the remainder 
of the metals are entirely unsatisfactory, and as far as 
evidence at present is concerned, one may conclude that 
they are entirely without value. 
Of the non-metallic inorganic compounds, those 
of selenium and arsenic merit consideration. The sole 
claim of the former rests with the unconfirmed obser-
vations of Todd, and its value is inconclusive until 
further work is done. Eggers results with tetramethyl 
arsonium gluconate show it to be clearly the most ef-
fective substance yet produced in the treatment of 
aniMal tumors. His results, of counse, await confirmation 
and trial in human cases to establish the value of his 
compound. 
Results with most of the organic compounds 
including a group of dyes have been most disappointing. 
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Some effect has been noted with amino acids and colchicine, 
but these await confirmation. While hormones have been 
rather generally discredited, the results of Ishihara 
with P. O. U. hormone should be checked. 
Some striking effects have been produced by 
bacterial growth products in aniMals. Especially has 
this been noted with filtrates of the meningococcus and 
Bacillus enteriditis, employed by Shwartzman; the menin-
gococcus filtrates used by Shear; and Bacillus coli and 
typhosus used by Thlran-Reynals. Coley's toxins have 
stood the test of time and are the sole chemotherapeutic 
cancer treatment havtng official recognition. While thier 
field of usefulness is liMited to sarcoma, especially 
those of the bones, a definite small percentage of cases 
are cured or greqtly benefitted by their use. Their 
effectiveness cannot be denied, but they are effective 
in such a small percentage of the cases, that they cannot 
be considereo specific. 
Marked beneficial effect was noted by two 
investigators working separately with irradiated auto-
genous blood in human cases. Further work with this 
method is indicated. 
At present, any possible value in fever therapy 
seems improbable. Some thorough, well controlled exper-
iments show that the thermal death time of a group of 
tumors exceeds t2at of the hosts, and human work has 
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been quite unsuccessful. Gases have shown very little 
therapeutic action. The water balRnce experiments of 
Shear were negative except for those in which bacterial 
growth products were used, these having already been 
discusseo_. 
Certain general criticisms of the work reviewed 
may be made. These are: reports on experiments in which 
too few subjects, human or animal, were used; failure to 
employ controls in numerous of the animal experiments; 
failure to give information necessary for independent 
evaluation of results; use of combined forms of treatment 
which renders evaluation of the incti vidual substances 
impossible; and reaching conclusions which are broader 
than the results of the experimental work justify. 
In agaln examining the reports reviewed, it 
C8.n safely be concluded that, while some substances 
have undoubtedly produced cures in a small portion of 
the animal and human tumors treated, no method has so 
far been proven effective in the constitutional treatment 
of cancer. There are a number of sUbstances which are 
quite promising and on whtch further evidence should be 
gathered. 
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IX 
SUMMARY 
(1). The need for and rational of specific 
constitutional methods of treatment of cancer is presented. 
(2). The history of the subject is given. 
(3). The substances and methods which have been 
used in animal and human cancer are classifted and their 
results reviewed. 
(4). General criticisms of the investigations 
reviewed are made. 
(5). Some sUbstances have been shown to have 
cured otherwise hopeless cases of cancer, and early 
results with a few sUbstances suggest that they may 
eventually be proven of value. 
(6). There is at present, however, no proven 
effective specific constitutional treatment of cancer. 
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